JPWO2019144102A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019144102A5
JPWO2019144102A5 JP2020561572A JP2020561572A JPWO2019144102A5 JP WO2019144102 A5 JPWO2019144102 A5 JP WO2019144102A5 JP 2020561572 A JP2020561572 A JP 2020561572A JP 2020561572 A JP2020561572 A JP 2020561572A JP WO2019144102 A5 JPWO2019144102 A5 JP WO2019144102A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
e4orf1
sci
administered
npc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512148A5 (https=
JP7391308B2 (ja
JP2021512148A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/014497 external-priority patent/WO2019144102A1/en
Publication of JP2021512148A publication Critical patent/JP2021512148A/ja
Publication of JP2021512148A5 publication Critical patent/JP2021512148A5/ja
Publication of JPWO2019144102A5 publication Critical patent/JPWO2019144102A5/ja
Application granted granted Critical
Publication of JP7391308B2 publication Critical patent/JP7391308B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561572A 2018-01-22 2019-01-22 脊髄損傷の治療のための組成物および方法 Active JP7391308B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862620269P 2018-01-22 2018-01-22
US62/620,269 2018-01-22
PCT/US2019/014497 WO2019144102A1 (en) 2018-01-22 2019-01-22 Compositions and methods for treatment of spinal cord injury

Publications (4)

Publication Number Publication Date
JP2021512148A JP2021512148A (ja) 2021-05-13
JP2021512148A5 JP2021512148A5 (https=) 2022-02-24
JPWO2019144102A5 true JPWO2019144102A5 (https=) 2022-02-24
JP7391308B2 JP7391308B2 (ja) 2023-12-05

Family

ID=67301897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561572A Active JP7391308B2 (ja) 2018-01-22 2019-01-22 脊髄損傷の治療のための組成物および方法

Country Status (7)

Country Link
US (1) US20210030810A1 (https=)
EP (1) EP3743085A4 (https=)
JP (1) JP7391308B2 (https=)
CN (1) CN111886016A (https=)
AU (1) AU2019209439A1 (https=)
CA (1) CA3089324A1 (https=)
WO (1) WO2019144102A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3512937B1 (en) 2016-09-13 2024-10-09 Angiocrine Bioscience, Inc. Blood-brain barrier comprising engineered endothelial cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089448A2 (en) * 2007-01-19 2008-07-24 Cornell Presearch Foundation, Inc. Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
AU2015279552B2 (en) * 2014-06-27 2021-01-21 Angiocrine Bioscience, Inc. Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
KR101675123B1 (ko) * 2014-06-27 2016-11-14 연세대학교 산학협력단 Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 허혈성 질환 또는 신경염증 질환 치료용 조성물
ES2815537T3 (es) * 2015-06-26 2021-03-30 S Biomedics Composición para el tratamiento de enfermedades isquémicas o trastornos inflamatorios neurogénicos, que contienen el secretoma de células progenitoras neurales como ingrediente activo
CN108291196B (zh) * 2015-07-20 2021-08-27 安吉克莱茵生物科学有限公司 表达ets转录因子的工程化的内皮细胞

Similar Documents

Publication Publication Date Title
Xu et al. Effects of electrical stimulation on skin surface
US20240301389A1 (en) Methods and Systems for Generation, Use, and Delivery of Activated Stem Cells
Grossman Effects of stimulation of non-specific thalamic system on locomotor movements in cat
EP1658853A4 (en) MEDIUM FOR INTERNAL ADMINISTRATION FOR DISEASES OF NERVES IN THE HEAD WITH MESENCYCLES AS AN ACTIVE SUBSTANCE
Mofrad et al. The effect of conductive aligned fibers in an injectable hydrogel on nerve tissue regeneration
EP3373996B1 (en) Method for generation, use and delivery of activated stem cells
Oh et al. Conductive polymers to modulate the post-stroke neural environment
JP2020511548A (ja) 治療用のボツリヌス神経毒素
CN119424659B (zh) 一种脑靶向纳米载体及其制备方法与应用
JP2021512148A5 (https=)
JPWO2019144102A5 (https=)
JP2022502379A (ja) 細胞外マトリクスの合成を促進するグルコサミンのアミノ酸誘導体、及びこれを含む医薬組成物
RU2120289C1 (ru) Способ лечения больных с неврологическими проявлениями остеохондроза позвоночника
Zhang et al. Smart Response Biomaterials for Pain Management
US5981508A (en) Facilitation of repair of neural injury with CM101/GBS toxin
Manni et al. Mesodiencephalic representation of the eye muscle proprioception
JP2009504636A (ja) 血漿または血清を含む神経損傷治療用の医薬組成物
CN119632964B (zh) 苯磺酰胺在制备治疗周围神经粘连类疾病药物中的应用
CA2575827A1 (en) Antiepileptogenic complex of albumin with docosahexaenoate
RU2666942C1 (ru) Способ лечения полинейромиопатии критических состояний у реанимационных больных
US20220023623A1 (en) Sonic hedgehog delivery
Wang et al. Liquid metal enabled electrobiology: A generalized easy going way to tackle disease challenges
RU2778425C2 (ru) Способ и система для генерации и использования активированных стволовых клеток
RU2462280C1 (ru) Способ цитофлавин-электрокумуляции при лечении сосудистых и дистрофических заболеваний сетчатки и зрительного нерва
US20210008102A1 (en) Regenerative co2 treatment apparatus and method